- Home
- INTS vs SSM Comparison
INTS vs SSM Comparison
Compare INTS & SSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- SSM
- Stock Information
- Founded
- INTS 2012
- SSM N/A
- Country
- INTS United States
- SSM Germany
- Employees
- INTS N/A
- SSM 43
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- SSM
- Sector
- INTS Health Care
- SSM
- Exchange
- INTS Nasdaq
- SSM Nasdaq
- Market Cap
- INTS 12.2M
- SSM 9.9M
- IPO Year
- INTS 2023
- SSM N/A
- Fundamental
- Price
- INTS $0.42
- SSM $6.64
- Analyst Decision
- INTS Strong Buy
- SSM
- Analyst Count
- INTS 4
- SSM 0
- Target Price
- INTS $4.50
- SSM N/A
- AVG Volume (30 Days)
- INTS 87.5M
- SSM N/A
- Earning Date
- INTS 11-06-2025
- SSM N/A
- Dividend Yield
- INTS N/A
- SSM N/A
- EPS Growth
- INTS N/A
- SSM N/A
- EPS
- INTS N/A
- SSM N/A
- Revenue
- INTS N/A
- SSM N/A
- Revenue This Year
- INTS N/A
- SSM N/A
- Revenue Next Year
- INTS N/A
- SSM N/A
- P/E Ratio
- INTS N/A
- SSM N/A
- Revenue Growth
- INTS N/A
- SSM N/A
- 52 Week Low
- INTS $0.19
- SSM N/A
- 52 Week High
- INTS $3.18
- SSM N/A
- Technical
- Relative Strength Index (RSI)
- INTS 50.05
- SSM N/A
- Support Level
- INTS $0.38
- SSM N/A
- Resistance Level
- INTS $0.50
- SSM N/A
- Average True Range (ATR)
- INTS 0.07
- SSM 0.00
- MACD
- INTS -0.02
- SSM 0.00
- Stochastic Oscillator
- INTS 18.75
- SSM 0.00
About INTS Intensity Therapeutics Inc.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About SSM Sono Group N.V. Ordinary Shares
Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and Services includes Complete Solar Solutions, Solar Charge Controllers, Solar Modules, and Data Services and Engineering Services.